Philip Frost
Publications by Year
Research Areas
Cancer Genomics and Diagnostics, Immunotherapy and Immune Responses, Cancer Research and Treatments, Fire effects on ecosystems, Virus-based gene therapy research
Most-Cited Works
- → Enhanced sensitivity of PTEN-deficient tumors to inhibition of FRAP/mTOR(2001)973 cited
- → Interleukin-2 production by tumor cells bypasses T helper function in the generation of an antitumor response(1990)922 cited
- → Identification of p53 Gene Mutations in Bladder Cancers and Urine Samples(1991)893 cited
- → Identification of ras Oncogene Mutations in the Stool of Patients with Curable Colorectal Tumors(1992)700 cited
- → Clonal Origin of Bladder Cancer(1992)539 cited
- → Combinatorial chemoprevention of intestinal neoplasia(2000)494 cited
- → mTOR, a novel target in breast cancer: the effect of CCI-779, an mTOR inhibitor, in preclinical models of breast cancer.(2001)418 cited
- SKI-606, a 4-anilino-3-quinolinecarbonitrile dual inhibitor of Src and Abl kinases, is a potent antiproliferative agent against chronic myelogenous leukemia cells in culture and causes regression of K562 xenografts in nude mice.(2003)
- → Antibody-targeted chemotherapy with CMC-544: a CD22-targeted immunoconjugate of calicheamicin for the treatment of B-lymphoid malignancies(2003)354 cited
- → Unknown primary carcinoma: natural history and prognostic factors in 657 consecutive patients.(1994)344 cited